These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18182242)
1. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958. Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242 [TBL] [Abstract][Full Text] [Related]
2. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
3. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor. Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582 [TBL] [Abstract][Full Text] [Related]
4. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism. Gera L; Fortin JP; Adam A; Stewart JM; Marceau F J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899 [TBL] [Abstract][Full Text] [Related]
6. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related]
7. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity. Miskolzie M; Gera L; Stewart JM; Kotovych G J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET. Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086 [TBL] [Abstract][Full Text] [Related]
9. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake. Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517 [TBL] [Abstract][Full Text] [Related]
10. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging. Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624 [TBL] [Abstract][Full Text] [Related]
11. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography. Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412 [TBL] [Abstract][Full Text] [Related]
12. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Stewart JM; Gera L; Chan DC; York EJ; Simkeviciene V; Bunn PA; Taraseviciene-Stewart L Peptides; 2005 Aug; 26(8):1288-91. PubMed ID: 15878795 [TBL] [Abstract][Full Text] [Related]
13. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity. Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human and rabbit arterial smooth muscle cell migration mediated by the kinin B1 receptor: role of receptor density and released mediators. Morissette G; Sabourin T; Adam A; Marceau F Can J Physiol Pharmacol; 2006 Nov; 84(11):1107-19. PubMed ID: 17218975 [TBL] [Abstract][Full Text] [Related]
15. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists. Morissette G; Bouthillier J; Marceau F Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151 [TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor. Fathy DB; Kyle DJ; Leeb-Lundberg LM Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta enhances the action of bradykinin in rat myenteric neurons through up-regulation of glial B1 receptor expression. Murakami M; Ohta T; Ito S Neuroscience; 2008 Jan; 151(1):222-31. PubMed ID: 18053651 [TBL] [Abstract][Full Text] [Related]
18. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. Lim SK; Han HJ; Kim KY; Park SH J Cell Physiol; 2009 Dec; 221(3):677-87. PubMed ID: 19725054 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist. Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953 [TBL] [Abstract][Full Text] [Related]
20. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation. Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]